CEBPA and fatty liver disease: Acacetin effectively attenuated the gene expressions of C/EBPα, C/EBPβ, Srebp-1c, and FAS, confirming that acacetin decreased TGs in the liver by reducing lipid synthesis and thus improving liver steatosis in obese mice.